• Mammogram screening and overdiagnosis: tumor size an issue?

    Hologic Imaging MachineDOTmed.com – Health Care Business Daily News
    Written by: Thomas Dworetzky , Contributing Reporter

    A just-published study of breast cancer data has raised the issue of overdiagnosis from mammography screening – and puts tumor size squarely in the middle of the debate.

    That’s because many “small breast cancers have an excellent prognosis because they are inherently slow-growing,” according to Yale Cancer Center experts in a June 8th New England Journal of Medicine report, which weighed in on the benefits of breast cancer early detection.

    Frequently these smaller tumors come from slow-growing cancers that may not become an issue during a patient’s lifetime, they noted. [Read More…]

  • The Radiant Health Show with Dr. Christine Horner – Carla Garcia, C.T., D.O.M

    Is Thermography a Mammogram Alternative?
    Part 1 and 2
    September 14, 2016

    Dr. Carla Garcia

     

     

    My guest this week is Dr. Carla Garcia, a board certified Doctor of Oriental Medicine with more than 30 years of experience in Integrative Medicine and an expert in thermography.

    In this 2-part interview, she discusses thermography, how it is useful for breast tissue examination and how it differs from mammography.

    http://www.spreaker.com/show/the-radiant-health-shows-tracks

  • American Cancer Society abandons ‘one size fits all’ advice on mammograms

    mammograms

    By Karen Kaplan – Contact Report
    Los Angeles Times – October 20, 2015

    After a thorough review of the benefits and limitations of mammograms, the nation’s top cancer-fighting organization is advising women that they can wait until they are 45 years old to start using the tests to screen for breast cancer.

    New guidelines from the American Cancer Society also assure women that they can have fewer mammograms over the course of their lives.

    The guidelines, published in Wednesday’s edition of the Journal of the American Medical Assn., are designed for women who are in good health and have no reason to suspect their risk of developing breast cancer is above average. The findings represent a departure from the group’s previous recommendation that all women with an average risk of breast cancer get annual mammograms starting at age 40.

    The American Cancer Society has updated its guidelines for average risk women.

    Although the American Cancer Society still endorses that course for women who prefer it, the group acknowledged that some women favor a less-aggressive approach to breast cancer screening. If so, it said, they can delay their first mammogram until they are 45 and wait two years between screenings starting at age 55 without fear that doing so will put their health in jeopardy.

    Either way, regular mammograms should continue as long as women have a life expectancy of at least 10 years and are good candidates for breast cancer treatment, the guidelines say. [Read More…]

  • U.S. breast cancer cases to increase 50 percent by 2030: NCI report

    April 22, 2015

    by Lisa Chamoff , DOTmed contributing reporter

    Signs-of-Breast-CancerThe number of breast cancer cases in the U.S. will be 50 percent higher in 2030 than it was in 2011, with an estimated 441,000 cases in 15 years, according to new research by the National Cancer Institute (NCI).

    The research, presented this week at the American Association for Cancer Research annual meeting, shows a marked increase in estrogen receptor (ER)-positive tumors in women older than 70. Part of the increase is due to the fact that women are living longer, and also due to screening technology that enables doctors to diagnose smaller, in situ tumors and invasive tumors, which are mostly detected via mammography.

    The forecast comes the same week that the U.S. Preventive Services Task Force updated, but did not change, its breast cancer screening recommendations, which state that women age 50 to 74 should only be screened once every two years, while women in their 40s should discuss screening with their doctors. [Read More…]

  • USPSTF new breast screening recommendations ‘would result in thousands of breast cancer deaths’: ACR

    April 21, 2015

    by Lauren Dubinsky , Staff Writer

    Breast Cancer Word Cloud ConceptThe U.S Preventive Services Task Force (USPSTF) released the draft update for its breast cancer screening recommendations on Monday — but not much has changed from the 2009 recommendations. The recommendations state that women between ages 50 and 74 should only undergo routine biennial screening and women in their 40s should discuss with their physician whether they need screening.

    On the their website, the Task Force gives screening women ages 40 to 49 a “C” recommendation and wrote, “Women who place a higher value on the potential benefit than the potential harms may choose to begin screening between the ages of 40 and 49 years.” The Task Force gave screening women ages 50 to 74 a “B” recommendation. [Read More…]

  • Mandatory Reporting Of Breast Density In Screening Mammograms. Why The Controversy

    Elaine Schattner
    www.forbes.com

    imagesRecently, the Governor of Michigan signed into law a requirement that radiologists inform women if their mammogram reveals dense breasts. The law will take effect on June 1, 2015. With this act, Michigan became the 21st state to enact legislation on mandatory reporting of breast density found in breast cancer screening.

    The surprisingly controversial law, having to do with a woman’s right to know if her mammogram result is unclear, may go national: Last July, Senators Dianne Feinstein (D-Calif.) and Kelly Ayotte (R-N.H.) introduced the Breast Density and Mammography Reporting Act. Similar legislation repeatedly has been put before Congress by Rep. Rosa DeLauro (D-CT) and co-sponsors. [Read More…]

  • From the ED: Breast Cancer Mammograms: Overrated – and Over-diagnosing Women

    Posted on June 23, 2014
    by Caitlin C.
    Posted at:  Breast Cancer Action

    Editor’s Note: You may have seen Karuna’s article back in April of this year when it was published in The Guardian. The piece generated a lot of discussion – over 1,000 people shared it on their Facebook page and over 150 people commented on the article itself. Many of you who have been through several iterations of these debates are used to the controversy that arises from publicly challenging routine mammography screening. What’s new this time around is the growing agreement that the benefits of routine mammography screening have long been overstated, and the harms long underestimated. Ten years ago, our challenge to the conventional position that “early detection saves lives” and “early detection is your best protection” was highly unpopular. Our independent position was a hard truth for many to hear even though it was grounded in evidence because it went against the grain of pretty much every mainstream breast cancer organization—many of which were and still are heavily invested (both in terms of funders and core values) in the “early detection saves lives” philosophy. We’ve reached a tipping point recently and now increasingly we hear more discussion about this issue and less unquestioned acceptance of the earlier screening messages.Karuna-Jaggar-headshot-2014-150x150

    By Karuna Jaggar, Executive Director

    How will we ever hope to make desperately needed progress in the breast cancer epidemic when the mainstream breast cancer movement continues to push an outdated and scientifically debunked agenda? The evidence has been mounting that the time has come to radically re-think the tenets of the breast cancer awareness movement because it is clear that the fundamental philosophy behind “early detection” is flawed. [Read More…]

  • Mammography controversy needs greater participation to inform decisions

    Wednesday 7 May 2014 – 2am PST

    Doctors at the World Congress on the Menopause in Cancun, Mexico, have called for any decision to participate in mammography to be a based on an informed choice and consideration of all factors, rather than just be an automatic process.

    A major session at the World Congress on the Menopause has debated the benefits and risks associated with regular mammography. The potential benefit of mammography is earlier detection of breast cancer, but increasing evidence has shown that mammography also uncovers some cancers which would not go onto cause any problem, and many doctors believe that this over diagnosis can cause real harm through unnecessary treatment. The debate in the scientific press has led to confusion in the minds of many women, who hope for a definitive answer on whether or not they should undergo regular mammography.

    Now two prominent doctors from opposing sides of the debate have agreed that women need to be more involved in making decisions on whether or not mammography is right for them.

    Dr Eugenio Paci presented work from the EUROSCREEN working group, showing that over diagnosis is at the lower end of the estimates, indicating that mammography saves lives. This work indicates that screening 1000 women saves up to 7 lives, with only 4 over diagnosis. Professor Robin Bell presented an analysis showing that up to 40% of invasive breast cancer cases identified in women invited for mammography may be over diagnosed, and says that the total number of deaths in screened patients does not drop when measured against non-screened patients, indicating that screening has few benefits. [Read More…]

  • Abolishing Mammography Screening Programs? A View from the Swiss Medical Board

    Nikola Biller-Andorno, M.D., Ph.D., and Peter Jüni, M.D.

    April 16, 2014DOI: 10.1056/NEJMp1401875

    In January 2013, the Swiss Medical Board, an independent health technology assessment initiative under the auspices of the Conference of Health Ministers of the Swiss Cantons, the Swiss Medical Association, and the Swiss Academy of Medical Sciences, was mandated to prepare a review of mammography screening. The two of us, a medical ethicist and a clinical epidemiologist, were members of the expert panel that appraised the evidence and its implications. The other members were a clinical pharmacologist, an oncologic surgeon, a nurse scientist, a lawyer, and a health economist. As we embarked on the project, we were aware of the controversies that have surrounded mammography screening for the past 10 to 15 years. When we reviewed the available evidence and contemplated its implications in detail, however, we became increasingly concerned.

    First, we noticed that the ongoing debate was based on a series of reanalyses of the same, predominantly outdated trials. The first trial started more than 50 years ago in New York City and the last trial in 1991 in the United Kingdom. None of these trials were initiated in the era of modern breast-cancer treatment, which has dramatically improved the prognosis of women with breast cancer. Could the modest benefit of mammography screening in terms of breast-cancer mortality that was shown in trials initiated between 1963 and 1991 still be detected in a trial conducted today? [Read More…]

  • Are the Harms of Mammography Underestimated?

    April 08, 2014

    By Kristen Fischer

    More controversy has emerged surrounding mammograms ever since a new report in JAMA recommended that the test be performed based on a woman’s risk and preferences.
    Dr. Lydia Pace and Dr. Nancy Keating both of Brigham and Women’s Hospital in Boston, conducted a systematic review of data spanning 50 years. They examined about 450 studies from 1960 through the present to look for evidence on the benefits and harms of the diagnostic test.

    According to their report, annual mammograms lower mortality from breast cancer by about 19 percent, though the benefits vary based on a woman’s risk and age. Approximately 1,904 women in their 40s would have to undergo a mammogram to prevent one death, while the same would be true for 377 women in their 60s. The disease is more common as a woman ages. At 40, the risk for breast cancer in the next 10 years is 1.5 percent, but that rises to 2.3 percent by age 50, and 3.5 percent by age 60. [Read More…]